Akèy › Maladi atè perifèrik
Etid klinik pou Maladi atè perifèrik ap rekrite nan Etazini
69 etid pou Maladi atè perifèrik ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Chicago, IL9 etid
- Dallas, TX9 etid
- Cleveland, OH9 etid
- Boston, MA9 etid
- Houston, TX8 etid
- Omaha, NE7 etid
- Gainesville, FL7 etid
- Minneapolis, MN6 etid
- Nashville, TN6 etid
- Aurora, CO6 etid
- Miami, FL6 etid
- Houma, LA5 etid
- Atlanta, GA5 etid
- Detroit, MI5 etid
- Providence, RI5 etid
- New York City, NY5 etid
- Philadelphia, PA5 etid
- Norfolk, VA5 etid
- New Haven, CT5 etid
- Greenville, SC5 etid
- Milwaukee, WI4 etid
- Oklahoma City, OK4 etid
- Plano, TX4 etid
- Orlando, FL4 etid
- Portland, OR4 etid
- Tampa, FL4 etid
- Knoxville, TN4 etid
- Columbus, OH4 etid
- Richmond, VA4 etid
- Los Angeles, CA4 etid
- Durham, NC4 etid
- Tucson, AZ4 etid
- Washington, DC4 etid
- Harrisburg, PA3 etid
- Pittsburgh, PA3 etid
- Lakeland, FL3 etid
- Baton Rouge, LA3 etid
- St. Petersburg, FL3 etid
- Charlotte, NC3 etid
- Austin, TX3 etid
Pa eta
- Alabama4 etid
- Arizona9 etid
- Arkansas3 etid
- Colorado8 etid
- Connecticut7 etid
- Florid17 etid
- Georgia6 etid
- Illinois11 etid
- Indiana4 etid
- Iowa4 etid
- Kalifòni13 etid
- Kentucky3 etid
- Lwizyàn9 etid
- Maryland4 etid
- Massachusetts11 etid
- Michigan9 etid
- Minnesota9 etid
- Missouri5 etid
- Nebraska8 etid
- New Hampshire3 etid
- New Jersey6 etid
- New York8 etid
- North Carolina9 etid
- Ohio14 etid
- Oklahoma5 etid
- Oregon4 etid
- Pennsylvania10 etid
- Rhode Island5 etid
- South Carolina7 etid
- Tennessee14 etid
- Texas20 etid
- Virginia10 etid
- Wisconsin6 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
EVERO Drug-coated Balloon (DCB) Randomized Trial
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07144150Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07318610Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07223593Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05485961Detecting Peripheral Artery Disease With the Pulse
Ap rekriteVolontè an sante akeyi
Laj 19 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07226193Intervascular Post-Market Clinical Follow-Up (PMCF) Registry
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT07322913Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT07613840Advanta VXT and Flixene PMCF Registry
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT07161583Community-based Exercise Following Revascularization for PAD
Ap rekrite
Laj 40 a 90 · Tout sèks · Mizajou Sep 9, 2026 · NCT04252950Evaluating the Efficacy of Perinatal Membrane Allografts in Addition to the Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers.
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06437028The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 27, 2026 · NCT06321575Leg Heat Therapy in Peripheral Artery Disease
Ap rekrite
Laj 50 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT05465070CRUSH PAD: Real-world Outcomes Following Use of Shockwave Intravascular Lithotripsy (IVL) Technology in Calcified Common Femoral Lesions
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 14, 2026 · NCT05145478Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System
Ap rekriteEtid obsèvasyon
Laj 22 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT07335341Response to Exercise and Nitric Oxide in PAD
Ap rekriteFaz 2
Laj 50 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT06657976Vascular Trial Associated Registry Pilot
Ap rekriteFaz 4
Laj 45 ak plis · Tout sèks · Mizajou Jul 16, 2026 · NCT07076082Intravascular Ultrasound Imaging Guidance for Optimal Revascularization of Limb Arteries
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 9, 2026 · NCT07353905Use of Thermal Imaging Camera to Assess Perfusion Before and After Vascular Intervention
Ap rekriteEtid obsèvasyon
Laj 18 a 99 · Tout sèks · Mizajou Jul 2, 2026 · NCT06544135The Pharmacokinetics and Pharmacodynamics Study of Evategrel CG-0255 Besylate）and Plavix® in Healthy Participants
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 55 · Tout sèks · Mizajou Jun 29, 2026 · NCT07619885Impact of Nrf2 Activation on Macrovascular, Microvascular & Leg Function & Walking Capacity in Peripheral Artery Disease
Ap rekriteFaz 1 bonèVolontè an sante akeyi
Laj 50 a 75 · Tout sèks · Mizajou Jun 24, 2026 · NCT06319339Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 17, 2026 · NCT06300450The THOR IDE Study
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 11, 2026 · NCT05916950The Effects of a Novel, Non-ischemic and Pain-free Exercise Intervention in Peripheral Artery Disease
Ap rekrite
Laj 40 ak plis · Tout sèks · Mizajou May 29, 2026 · NCT05712395The COCOA-PAD II Trial
Ap rekriteFaz 3
Laj 55 ak plis · Tout sèks · Mizajou May 28, 2026 · NCT04794530The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou May 13, 2026 · NCT05811364Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.